Matthew R Cooperberg MD MPH, FACS
Surgical Oncology
Helen Diller Family Professor, Department of Urology, UCSF
Join to View Full Profile
1825 4th StSan Francisco, CA 94143
Phone+1 415-476-4616
Fax+1 415-514-6195
Dr. Cooperberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Urology, 2002 - 2008
Yale-New Haven Medical CenterInternship, Transitional Year, 2000 - 2001
Yale School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - 2028
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2016-2017
Clinical Trials
- Pioneering Advances in Care and Education (PACE) Start of enrollment: 2018 Jul 19
Publications & Presentations
PubMed
- Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI.Jeffrey J Tosoian, Jacob I Meyers, Bradley Moore, Cameron J Britton, Kent Chevli
The Journal of Urology. 2026-04-28 - Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer.Deondre D Do, Mariluz Rojo Domingo, Christopher C Conlin, Ian Matthews, Karoline Kallis
Cancer Imaging. 2026-04-16 - A single-cell and spatial atlas of prostate cancer reveals the combinatorial nature of gene modules underlying lineage plasticity and metastasis.Hanbing Song, Junxiang Xu, Keila Velazquez-Arcelay, Arda Demirci, Brendan L Raizenne
Biorxiv. 2026-03-27
Journal Articles
- Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the USPeter E Lonergan, Matthew R Cooperberg, JAMA Network Open
- Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the Internationa...Michael J Zelefsky, Matthew R Cooperberg, Brian J Davis, Eric M Horwitz, Martha K Terris, Christopher L Amling, Christopher J Kane, Curtiland Deville, Theodore L Dewee..., JAMA Oncology
- Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityMatthew R Cooperberg, Atreya Dash, JAMA Oncology
Authored Content
- Androgen Deprivation Therapy and the Risk of Dementia After Treatment for Prostate CancerDecember 2021
- Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityAugust 2020
- The Diverse Genomic Landscape of Clinically Low-Risk Prostate CancerMay 2018
Press Mentions
Is MRI Alone Reliable for Prostate Cancer Monitoring?November 25th, 2025- Vast Majority of Americans Don't Know Early PCa Has Zero Symptoms, Ohio State Survey ConfirmsSeptember 28th, 2025
- UCSF Awarded $12M Research Grant to Improve Cancer OutcomesSeptember 23rd, 2025
Grant Support
- Multimodality spatial analysis in prostate cancer to improve prognostic estimation and cast light into the black box of pathology artificial intelligence algorithmsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2025–2029
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
